Woman's World on MSN4d
7 Doctor-Backed COPD Treatments That Help You Breathe Easier (Hint: Tai Chi!)
Sure, having a cold or respiratory infection can temporarily make it harder to breathe. But if excessive coughing and ...
Remote monitoring: Upgrading chronic care and addiction management in Scotland
By harnessing big data and machine learning (ML), a new generation of remote monitoring devices developed in Scotland is ...
Nature15d
Chronic obstructive pulmonary disease articles from across Nature Portfolio
Chronic obstructive pulmonary disease (COPD) is a disease of the respiratory tract that is characterized narrowing of the small airways and destruction of lung tissue. This leads to poor airflow ...
The American Journal of Managed Care2d
CHEST: American College of Chest Physicians Annual Meeting
Chronic obstructive pulmonary disease (COPD) presents a significant ... panelists at the CHEST Annual Meeting 2023 shared sobering statistics and important considerations in treating patients ...
STAT22d
Regeneron, Sanofi blockbuster Dupixent wins FDA approval for COPD
Dupixent is already a blockbuster therapy for a range of immune-mediated diseases, but the Food and Drug Administration’s approval of the drug for chronic obstructive pulmonary disease greatly ...
The Financial Express2d
How does smoking affects your skin?
Smoking is responsible for decreasing the body’s inflammatory process and immune function (due to a reduced blood flow), ...
clickondetroit.com7d
What’s Going Around: Asthma, COPD, stomach viruses, fall allergies
If you need help with the Public File, call (313) 222-0556. At WDIV, we are committed to informing and delighting our audience. In our commitment to covering our communities with innovation and ...
The Advocate5d
An archeological dig through Smiley's desk reveals that his spirit is still going strong
Over the last two years, I was privileged to spend a lot of time with beloved newspaper columnist, Smiley Anders, and his ...
FiercePharma22d
Sanofi, Regeneron look to seize major opportunity with Dupixent's COPD approval
Over the last decade, as other companies—such as AstraZeneca with IL-5 inhibitor Fasenra—struggled to advance candidates for COPD, Regeneron and Sanofi took a more “phenotype-driven approach ...
UUHC Health Feed1y
Pulmonary Services
This can include many kinds of lung conditions, such as asthma, bronchitis, chronic obstructive pulmonary disease, pneumonia, cystic fibrosis, and others. University of Utah Health Pulmonary Services ...
The American Journal of Managed Care22d
FDA Approves Dupilumab as First Biologic Treatment for COPD
Dupixent approved in China as the first-ever biologic medicine for patients with chronic obstructive pulmonary disease (COPD). September 27, 2024. Accessed September 27, 2024.
Nasdaq22d
Dupixent® (dupilumab) Approved in China as the First-ever Biologic Medicine for Patients with Chronic Obstructive Pulmonary Disease (COPD)
Approval follows EU approval of Dupixent for adults with COPD with raised blood eosinophils, and is based on two landmark Phase 3 trials showing Dupixent significantly reduced exacerbations ...